P2RX7 and atherosclerosis: Moreover, we cannot exclude that statins44 assumed by patients providing for PLs could hamper the efficacy of MMPs inhibitors, while medications seemed not to interfere with P2X7 antagonism, further supporting the suitability of A740003 as a tool to modulate inflammatory status in atherosclerosis.